Wells Fargo’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-55,391
| Closed | -$3.99M | – | 7798 |
|
|
2020
Q4 | $3.99M | Buy |
55,391
+15,463
| +39% | +$809K | ﹤0.01% | 2948 |
|
|
2020
Q3 | $1.82M | Sell |
39,928
-2,773
| -6% | -$116K | ﹤0.01% | 3386 |
|
|
2020
Q2 | $1.93M | Buy |
42,701
+1,143
| +3% | +$51.2K | ﹤0.01% | 3283 |
|
|
2020
Q1 | $1.6M | Sell |
41,558
-22,835
| -35% | -$1.05M | ﹤0.01% | 3192 |
|
|
2019
Q4 | $2.98M | Sell |
64,393
-33,428
| -34% | -$1.45M | ﹤0.01% | 3011 |
|
|
2019
Q3 | $3.98M | Sell |
97,821
-62,540
| -39% | -$2.7M | ﹤0.01% | 2745 |
|
|
2019
Q2 | $7.72M | Sell |
160,361
-105,264
| -40% | -$5.53M | ﹤0.01% | 2171 |
|
|
2019
Q1 | $16.6M | Buy |
265,625
+67,306
| +34% | +$4.62M | 0.01% | 1567 |
|
|
2018
Q4 | $11.8M | Buy |
198,319
+67,490
| +52% | +$4.05M | ﹤0.01% | 1748 |
|
|
2018
Q3 | $8.43M | Sell |
130,829
-15,956
| -11% | -$890K | ﹤0.01% | 2209 |
|
|
2018
Q2 | $6.61M | Buy |
146,785
+7,884
| +6% | +$314K | ﹤0.01% | 2433 |
|
|
2018
Q1 | $4.31M | Sell |
138,901
-240,171
| -63% | -$7.9M | ﹤0.01% | 2753 |
|
|
2017
Q4 | $11.3M | Sell |
379,072
-49,652
| -12% | -$1.44M | ﹤0.01% | 1905 |
|
|
2017
Q3 | $14.1M | Sell |
428,724
-60,941
| -12% | -$2.11M | ﹤0.01% | 1687 |
|
|
2017
Q2 | $16.4M | Sell |
489,665
-87,978
| -15% | -$2.62M | 0.01% | 1523 |
|
|
2017
Q1 | $16.7M | Sell |
577,643
-118,069
| -17% | -$2.92M | 0.01% | 1499 |
|
|
2016
Q4 | $15.5M | Buy |
695,712
+5,211
| +0.8% | +$102K | 0.01% | 1537 |
|
|
2016
Q3 | $12.8M | Sell |
690,501
-57,231
| -8% | -$1.08M | ﹤0.01% | 1582 |
|
|
2016
Q2 | $12.2M | Sell |
747,732
-280,040
| -27% | -$4.12M | ﹤0.01% | 1671 |
|
|
2016
Q1 | $12M | Buy |
1,027,772
+33,609
| +3% | +$376K | ﹤0.01% | 1646 |
|
|
2015
Q4 | $11.6M | Buy |
994,163
+119,328
| +14% | +$1.51M | ﹤0.01% | 1705 |
|
|
2015
Q3 | $10.7M | Buy |
874,835
+40,713
| +5% | +$519K | ﹤0.01% | 1760 |
|
|
2015
Q2 | $7.87M | Buy |
834,122
+489,511
| +142% | +$4.53M | ﹤0.01% | 2091 |
|
|
2015
Q1 | $3.05M | Buy |
344,611
+67,717
| +24% | +$684K | ﹤0.01% | 2737 |
|
|
2014
Q4 | $2.78M | Buy |
276,894
+43,598
| +19% | +$374K | ﹤0.01% | 2780 |
|
|
2014
Q3 | $1.56M | Buy |
233,296
+25,743
| +12% | +$181K | ﹤0.01% | 3151 |
|
|
2014
Q2 | $1.49M | Buy |
207,553
+62,288
| +43% | +$496K | ﹤0.01% | 3212 |
|
|
2014
Q1 | $1.47M | Buy |
145,265
+117,165
| +417% | +$1.08M | ﹤0.01% | 3204 |
|
|
2013
Q4 | $223K | Sell |
28,100
-500
| -2% | -$4.67K | ﹤0.01% | 4198 |
|
|
2013
Q3 | $283K | Sell |
28,600
-10,400
| -27% | -$81.9K | ﹤0.01% | 4029 |
|
|
2013
Q2 | $230K | Buy |
+39,000
| New | +$131K | ﹤0.01% | 4071 |
|
Other funds holding BEAT
Wells Fargo's BEAT Position: Q1 2021 in Review
Wells Fargo sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 55,391 shares — an estimated $3.99M sold.
Wells Fargo first reported a position in BEAT in Q2 2013 and held it in 31 quarters. The position peaked at $16.7M in Q1 2017. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Wells Fargo reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Wells Fargo sold 55,391 BioTelemetry, Inc. shares in Q1 2021, an estimated $3.99M.
- Wells Fargo first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 31 quarters.
- Wells Fargo's BioTelemetry, Inc. position peaked at $16.7M in Q1 2017.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.